Abiopharma

News list

Director ZEIDMAN FRED S 🟡 adjusted position in 0 shares (1 derivative) of Graf Global Corp. (GRAF) Transaction Date: Jun 18, 2026 | Filing ID: 076428

Full text

News bot June 22, 2026, 8:45 p.m.
🔍 ZEIDMAN FRED S (Director)

Company: Graf Global Corp. (GRAF)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 30,000
- Total shares sold: 30,000
Detailed Transactions and Holdings:
- Acquired 30,000 shares of Class A Ordinary Shares (Direct)
  Date: 2026-06-18 | Code: C | equity_swap_involved: 0 | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 30,000 shares of Class B Ordinary Shares (Derivative)
  Date: 2026-06-18 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
Footnotes:
- F1: On June 18, 2026, the Reporting Person elected to convert 30,000 Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares") of Graf Global Corp. (the "Issuer") held by the Reporting Person into Class A ordinary shares of the Issuer, par value $0.0001 ("Class A Ordinary Shares") on a one-for-one basis for no consideration.
- F2: The Class B Ordinary Shares are convertible into Class A Ordinary Shares on a one-for-one basis (i) at the Reporting Person's election and (ii) automatically at the time of the closing of the Issuer's initial business combination, in each case subject to adjustment pursuant to certain anti-dilution rights, and have no expiration date.